June 11th, 2013 – Shore Capital Partners announced an investment in InfuSource, a leading home infusion provider in Northern California.

June 25th, 2013 – Shore Capital Partners announced an investment into Quantum Physical Therapy and Michigan Rehabilitation Specialists of Davison which are leading physical therapy providers in Michigan.

August 5, 2013 – Shore Capital Partners (“Shore”), a healthcare-focused private equity firm, is pleased to announce the sale of its physical therapy portfolio company SCP Physical Therapy to ATI Physical Therapy, a nationally recognized comprehensive rehabilitation provider, specializing in research-based physical therapy, sports medicine, work conditioning/hardening, functional capacity assessments, aquatic health, hand therapy and women’s health.

In May 2012, Shore acquired and merged two physical therapy companies, Michigan Rehabilitation Specialists (“MRS”) and Excel Rehabilitation Services (“Excel”) into SCP Physical Therapy. Together, Shore and the company’s management expanded the company’s presence in Michigan from 17 clinics to 33 clinics through aggressive new clinic growth and two add-on acquisitions. Additionally, Shore and its operating partners provided operational expertise to develop and implement sophisticated metric management tools to improve and enhance the operations of the business.

“We are pleased to have supported SCP Physical Therapy’s development into the leading independent provider of outpatient physical therapy in Michigan,” said Justin Ishbia, Founder and Managing Partner of Shore Capital Partners. “This transaction validates our model of partnering with strong clinicians to grow local businesses into regional leaders.” “When we invested in MRS and Excel, we saw a tremendous opportunity to build on the companies’ clinical expertise and strong reputation in Michigan,” said Joseph Mooney, a Shore Capital Operating Partner who served as the full-time Chief Marketing Officer for SCP Physical Therapy. “We are pleased that the combination of management’s clinical expertise and Shore’s operational and financial support allowed the company to aggressively expand its footprint in Michigan and become an attractive strategic acquisition for ATI Physical Therapy.”

The transaction closed on August 5, 2013. Terms of the transaction are not disclosed. Winston & Strawn, LLP provided legal counsel to Shore.

This is the first realization for Shore, which was founded in 2009. Shore has completed 11 investments across the physical therapy, home infusion, lab services, and urgent care sectors.

About Michigan Rehabilitation Specialists and Excel Rehabilitation Services

Established in 1999 and 1994, respectively, MRS and Excel provide physical and occupational therapy for orthopedic injuries, work related injuries, sports injuries and various neurological and neuromuscular conditions. The combined companies operate 33 locations throughout Michigan. For additional information, please visit the company website at www.mrspt.com.

September 17, 2013 – Shore Capital Partners announced an investment in RapidCare Clinic, a leading provider of urgent care services throughout Tennessee.

November 25, 2013 – Shore Capital Partners (“Shore”), a healthcare-focused private equity firm, is pleased to announce the sale of its home infusion therapy portfolio company, SCP Specialty Infusion, to AxelaCare Health Solutions, a leading provider of specialty home infusion services specializing in IVIg (immune globulin).

In November 2009, Shore partnered with Chris York, CEO, and Mitch Friedman, CFO, long time home infusion industry veterans, to complete a roll-up strategy in the space. In July 2010, the management team and Shore made their platform investment in Arizona-based Sirona Infusion, LLC. Over the next three and a half years, Shore and management completed three add-on acquisitions and built three de novo pharmacies to become one of the largest privately-owned home infusion platforms in the country. Shore and management integrated these distinct and regionally diverse companies by standardizing operations with weekly and monthly metric management, a unified IT platform, and consolidated HR, corporate compliance, accounting and finance.

“We are pleased to have partnered with management to build SCP Specialty Infusion into one of the preeminent home infusion providers in the country,” said Justin Ishbia, Founder and Managing Partner of Shore Capital Partners. “Further, the successful execution of our value creation plan has allowed us to complete the sale of SCP Specialty Infusion on favorable terms for our investors.”

“Over the last three and a half years, we’ve built a company on the model of putting the patient first,” said Chris York, CEO of SCP Specialty Infusion. “We are confident that this model, combined with aggressive business development and an intense focus on metric management, enabled us to build a scarce asset in the home infusion industry. Shore’s operational oversight and financial support coupled with management’s industry expertise were highly complementary and helped facilitate the platform’s growth.”

The transaction closed on October 31, 2013. Terms of the transaction are not disclosed. Bass, Berry & Sims PLC provided legal counsel to SCP Specialty Infusion.

The sale of SCP Specialty Infusion marks the second successful realization for Shore, which was founded in 2009. In August, the firm announced in a press release the sale of its physical therapy platform, SCP Physical Therapy, to ATI Physical Therapy. Shore has completed 11 investments across the home infusion, lab services, physical therapy, and urgent care sectors.

About SCP Specialty Infusion

SCP Specialty Infusion, founded in 2010 with the acquisition of Sirona Infusion, LLC, is the premier provider of acute home infusion services in the Western U.S. Its network of pharmacies, infusion centers, and nursing staff spans Arizona, New Mexico, California, Colorado, and Oregon. Therapies delivered include the full spectrum of acute and chronic infusion therapies including anti-infective, oncolytic, total parenteral nutrition (TPN), cardiac, hydration, and other intravenously delivered medicines.